Is BIO-TECHNE Corp (TECH) Halal?
Shariah Screening — 5 Standards
Based on financial data from June 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 5.3% / 30% | 1.9% / 30% | 2.5% / 30% | 0.32% / 5% | ✓ HALAL |
| DJIM | 5.3% / 33% | 1.9% / 33% | 2.5% / 33% | 0.32% / 5% | ✓ HALAL |
| MSCI | 17.4% / 33% | 6.3% / 33% | 8.1% / 33% | 0.32% / 5% | ✓ HALAL |
| S&P | 5.3% / 33% | 1.9% / 33% | 2.5% / 33% | 0.32% / 5% | ✓ HALAL |
| FTSE | 17.4% / 33% | 6.3% / 33% | 8.1% / 50% | 0.32% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 66.6% | |
| Operating Margin | 19.7% | |
| Net Margin | 6.7% | |
| Return on Equity (ROE) | 4.0% | |
| Return on Assets (ROA) | 6.5% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $288M |
| Free Cash Flow | $257M |
| Total Debt | $444M |
| Debt-to-Equity | 17.4 |
| Current Ratio | 4.5 |
| Total Assets | $2.6B |
Price & Trading
| Last Close | $52.70 |
| 50-Day MA | $59.45 |
| 200-Day MA | $57.68 |
| Avg Volume | 2.4M |
| Beta | 1.5 |
|
52-Week Range
$46.01
| |
About BIO-TECHNE Corp (TECH)
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Purification Calculator
As a halal stock with 0.32% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is BIO-TECHNE Corp (TECH) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), BIO-TECHNE Corp is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is BIO-TECHNE Corp's debt ratio?
BIO-TECHNE Corp's debt ratio is 5.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 17.4%.
Does BIO-TECHNE Corp require dividend purification?
Yes, BIO-TECHNE Corp has an impermissible income ratio of 0.32%, which means 0.32% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are BIO-TECHNE Corp's key financial metrics?
BIO-TECHNE Corp has a market capitalization of $8.0B, trailing P/E ratio of 96.1, and revenue of $1.2B. The company maintains a gross margin of 66.6% and a net margin of 6.7%. Return on equity stands at 4.0%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.